STAR Systems International’s New Eagle Transponder and Titan Pro Lead the Way in Gen2V3 Solutions for Next-Generation Tolling
Notified -
Globe Newswire24-07-2025, 22:00
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00